On December 1, 2021 Eli Lilly and Company (NYSE: LLY) reported that it will host a meeting for the investment community on Wednesday, Dec. 15, 2021, from 9 a.m. to 4 p.m., Eastern time (Press release, Eli Lilly, DEC 1, 2021, View Source [SID1234596381]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Earlier that day, the company will announce its initial financial guidance for 2022, and at the meeting, Lilly leadership will further detail the 2022 financial guidance. A substantial portion of the meeting will cover Lilly’s research and development opportunities, with a focus on the early-phase pipeline, in the areas of diabetes, immunology, neuroscience and oncology.

In-person attendance is by invitation only and advance registration is required. Investors, media and the general public can access a live video webcast through a link that will be posted on Lilly’s website at View Source A replay of the presentation will be available on the website following the meeting.